4-Bromo-5,6-dihydro-7H-cyclopenta[c]pyridin-7-one, 98%, 250mg

N,N,2,4,6-pentamethylaniline, 98%, 1g

cyclopropyl 2-(2-thiomethylphenyl)ethyl ketone, 97.0%, 1g

4,4'-Bis(trifluoromethyl)biphenyl, 98.0%, 10g

Di-potassium oxalate monohydrate, min. 98.5%, pa, ACS, 250 g, plastic packaging.

(R)-tert-Butyl 1-(4-fluorobenzoyl)pyrrolidin-3-ylcarbamate, 95.0%, 1g

5-Chloronicotinaldehyde, 98.0%, 250mg

tert-Butyl N-[1-(2-bromophenyl)cyclopropyl]carbamate, 5g

METHYL 1-CYANOCYCLOPROPANECARBOXYLATE, 95.0%, 5g

1-Pentyl-1H-imidazole, 95.0%, 25g

(2R,4R)-2-(2-Chlorophenyl)-3-(4-(3,5-dimethylisoxazol-4-yl)benzoyl)thiazolidine-4-carboxylic acid, 99.0%, 10mg

PENTAGASTRIN, 98%, 5mg

Sodium (S)-6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide, 95.0%, 1g